Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 13-Oct-22 8:07 PM View:  | Jasper Therapeutics, Inc. (JSPR) | 12-Oct-22 | Grant | 24,500 | -- | -- | 100% 0 to 24.5K | |
| 14-Mar-22 6:03 PM View: | Crispr Therapeutics Ag (CRSP) | 14-Mar-22 | Payment of Exercise | 1,229 | $61.08 | $75,067.30 | (4%) 28.03K to 26.8K | |
| 14-Mar-22 6:03 PM View: | Crispr Therapeutics Ag (CRSP) | 11-Mar-22 | Payment of Exercise | 1,883 | $62.56 | $117,800.00 | (6%) 29.91K to 28.03K | |
| 14-Mar-22 6:03 PM View: | Crispr Therapeutics Ag (CRSP) | 11-Mar-22 | Option Exercise | 3,000 | -- | -- | 11% 26.91K to 29.91K | |
| 14-Mar-22 6:03 PM View: | Crispr Therapeutics Ag (CRSP) | 10-Mar-22 | Option Exercise | 4,584 | -- | -- | 21% 22.32K to 26.91K | |
| 07-Dec-21 8:00 PM View: | Crispr Therapeutics Ag (CRSP) | 06-Dec-21 | Payment of Exercise | 11,185 | $69.17 | $773,666.00 | (33%) 33.51K to 22.32K | |
| 07-Dec-21 8:00 PM View: | Crispr Therapeutics Ag (CRSP) | 03-Dec-21 | Option Exercise | 26,667 | -- | -- | 390% 6.84K to 33.51K | |
| 14-Sep-21 9:44 PM View: | Crispr Therapeutics Ag (CRSP) | 13-Sep-21 | Payment of Exercise | 4,207 | $117.86 | $495,837.00 | (38%) 11.05K to 6.84K | |
| 14-Sep-21 9:44 PM View: | Crispr Therapeutics Ag (CRSP) | 10-Sep-21 | Option Exercise | 10,000 | -- | -- | 952% 1.05K to 11.05K | |
| 25-Mar-21 5:39 PM View: | Crispr Therapeutics Ag (CRSP) | 23-Mar-21 | Option Exercise | 88,000 | $36.02 | $3,170,000.00 | 674% 13.05K to 101.05K | |
| 25-Mar-21 5:39 PM View: | Crispr Therapeutics Ag (CRSP) | 23-Mar-21 | Market Option Sale (Planned) | 88,000 | $128.05 | $11,268,600.00 | (87%) 101.05K to 13.05K | |
| 25-Mar-21 5:39 PM View: | Crispr Therapeutics Ag (CRSP) | 23-Mar-21 | Market Sale (Planned) | 12,000 | $128.05 | $1,536,630.00 | (92%) 13.05K to 1.05K | |
| 12-Mar-21 5:47 PM View: | Crispr Therapeutics Ag (CRSP) | 10-Mar-21 | Payment of Exercise | 2,141 | $124.15 | $265,805.00 | (14%) 15.19K to 13.05K | |
| 12-Mar-21 5:47 PM View: | Crispr Therapeutics Ag (CRSP) | 10-Mar-21 | Option Exercise | 4,583 | -- | -- | 43% 10.61K to 15.19K | |
| 20-Jan-21 6:07 PM View: | Crispr Therapeutics Ag (CRSP) | 15-Jan-21 | Option Exercise | 25,010 | $13.79 | $344,776.00 | 125% 19.99K to 45.0K | |
| 20-Jan-21 6:07 PM View: | Crispr Therapeutics Ag (CRSP) | 15-Jan-21 | Market Option Sale (Planned) | 25,000 | $215.20 | $5,379,940.00 | (56%) 45.0K to 20.0K | |
| 04-Jan-21 4:12 PM View: | Crispr Therapeutics Ag (CRSP) | 02-Jan-21 | Payment of Exercise | 9,392 | $153.11 | $1,438,010.00 | (47%) 20.0K to 10.61K | 0% |
| 23-Sep-20 7:04 PM View: | Dyne Therapeutics, Inc. (DYN) | 21-Sep-20 | Conversion | 10,725 | -- | -- | 100% 0 to 10.72K | |
| 26-Jun-20 4:33 PM View: | Crispr Therapeutics Ag (CRSP) | 25-Jun-20 | Option Exercise | 4,912 | $12.57 | $61,743.80 | 25% 20.0K to 24.91K | |
| 26-Jun-20 4:33 PM View: | Crispr Therapeutics Ag (CRSP) | 25-Jun-20 | Market Option Sale (Planned) | 4,912 | $75.18 | $369,272.00 | (20%) 24.91K to 20.0K | (130%) |
| 26-Jun-20 4:33 PM View: | Crispr Therapeutics Ag (CRSP) | 24-Jun-20 | Option Exercise | 65,088 | $8.58 | $558,707.00 | 325% 20.0K to 85.09K | |
| 26-Jun-20 4:33 PM View: | Crispr Therapeutics Ag (CRSP) | 24-Jun-20 | Market Option Sale (Planned) | 65,088 | $75.93 | $4,942,290.00 | (76%) 85.09K to 20.0K | (128%) |
| 13-May-20 4:38 PM View: | Crispr Therapeutics Ag (CRSP) | 11-May-20 | Option Exercise | 25,000 | $5.86 | $146,500.00 | 125% 20.0K to 45.0K | |
| 13-May-20 4:38 PM View: | Crispr Therapeutics Ag (CRSP) | 11-May-20 | Market Option Sale (Planned) | 25,000 | $60.40 | $1,509,970.00 | (56%) 45.0K to 20.0K | (187%) |
| 12-Jul-19 4:13 PM View: | Crispr Therapeutics Ag (CRSP) | 11-Jul-19 | Option Exercise | 8,421 | $5.86 | $49,347.10 | 42% 20.0K to 28.42K | |
| 12-Jul-19 4:13 PM View: | Crispr Therapeutics Ag (CRSP) | 11-Jul-19 | Market Option Sale (Planned) | 8,421 | $50.01 | $421,171.00 | (30%) 28.42K to 20.0K | (246%) |
| 12-Jul-19 4:13 PM View: | Crispr Therapeutics Ag (CRSP) | 10-Jul-19 | Option Exercise | 11,579 | $5.86 | $67,852.90 | 58% 20.0K to 31.58K | |
| 12-Jul-19 4:13 PM View: | Crispr Therapeutics Ag (CRSP) | 10-Jul-19 | Market Option Sale (Planned) | 11,579 | $50.02 | $579,182.00 | (37%) 31.58K to 20.0K | (246%) |
| 03-Jan-19 4:32 PM View: | Crispr Therapeutics Ag (CRSP) | 02-Jan-19 | Grant | 20,000 | $29.87 | $597,400.00 | 100% 0 to 20.0K | 480% |